Evidence map›Paper›PMID 41943212›Full record

ArticleThe Laryngoscope2026

A Health Systems Analysis of Global Head and Neck Cancer Outcomes.

Edward Christopher Dee, Adrian E Go, Erin Jay Garbes Feliciano, James Fan Wu, Jonas Willmann, Kaitlyn Lapen, Teeradon Treechairusame, Milit S Patel, Sruthi Ranganathan, Alessandro Hammond and 9 more

Abstract read
In one paragraph

Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Edward Christopher DeeDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0001-6119-0889
Adrian E GoCebu Institute of Medicine, Cebu City, Philippines.
Erin Jay Garbes FelicianoDepartment of Medicine, NYC+HHC/Elmhurst, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
James Fan WuDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.ORCID https://orcid.org/0000-0001-7447-6173
Jonas WillmannDepartment of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Kaitlyn LapenDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Teeradon TreechairusameDivision of Radiation Oncology, Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Milit S PatelDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Sruthi RanganathanDepartment of Medicine, University of Cambridge, Cambridge, UK.
Alessandro HammondDepartment of Biology, Harvard University, Cambridge, Massachusetts, USA.
Yingzhi WuDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Annu SinghDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0001-7066-4492
Andrew M WongCollege of Public Health, National Taiwan University, Taipei, Taiwan.
Luisa E JacominaDepartment of Radiation Oncology, Benavides Cancer Institute, University of Santo Tomas Hospital, Manila, Philippines.
Jennifer MaDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Puneeth IyengarDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Cherry L EstiloDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
T Peter KinghamDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Nancy Y LeeDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748Prostate Cancer Foundation Young Investigator Award
6 · The paper itself

Abstract

objectivesHead and neck cancer (HNC) remains a major global cause of cancer morbidity and mortality, with disproportionately poor outcomes in low- and middle-income countries. Substantial cross-national disparities suggest an important role for health system strengthening. We evaluated associations between national health system characteristics and global HNC outcomes.

methodsWe conducted a cross-sectional ecological analysis of 185 countries using sex-stratified, age-standardized incidence and mortality estimates from the International Agency for Research on Cancer (IARC) GLOBOCAN 2022 database. The primary outcome was the composite mortality-to-incidence ratio (MIR) for aggregated HNCs, including cancers of the lip and oral cavity, oropharynx, larynx, nasopharynx, hypopharynx, and salivary gland. Eleven national health system indicators capturing health financing, workforce density, service availability, socioeconomic development, and gender equity were evaluated. Univariable linear regressions identified candidate variables using Bonferroni correction (p < 0.0045), followed by multivariable modeling with assessment for multicollinearity using variance inflation factors.

resultsAll 11 health system indicators were significantly associated with HNC MIR on univariable analysis (p < 0.001 for all). In multivariable analysis of 123 countries with complete data, higher Universal Health Coverage (UHC) service coverage index and higher gross domestic product (GDP) per capita were independently associated with lower (improved) HNC MIR (model R

conclusionsAcross countries, progress toward universal health coverage and greater national economic capacity was independently associated with improved HNC outcomes. These findings may help to inform efforts at the level of health systems to improve HNC outcomes worldwide. LEVEL OF EVIDENCE: N/A.

Indexed as

Global HealthHead and Neck NeoplasmsCross-Sectional StudiesDeveloping CountriesFemaleHumansIncidenceMaleglobal oncologyGLOBOCANhead and neck cancershealth systemsmortality‐to‐incidence ratiouniversal health coverage

Identifiers

PMID41943212
PMCPMC13460493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.